<DOC>
	<DOCNO>NCT03080675</DOCNO>
	<brief_summary>To show efficacy 4-year intervention nutritional blend ingredient prevent cognitive decline .</brief_summary>
	<brief_title>Trial Nutritional Blend Prevent Cognitive Decline Older Adults</brief_title>
	<detailed_description>This multicenter trial placebo-controlled , double-blind , randomize , 2 parallel group study . The subject randomly allocate one two treatment group ( placebo nutrition product ) . The duration intervention 4 year . The total sample size baseline 2080 subject , consist non-demented adult subjective memory concern age 70+ year .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<criteria>1 . Age â‰¥ 70 year 2 . Spontaneous memory complaint 3 . Adequate fluency local language understand inform consent form complete study document 4 . Sufficient vision hear complete study protocol procedure base medical judgement 5 . Has study partner willing participate source information least weekly contact participant ( contact inperson , via telephone electronic communication ) 6 . Has general health status interfere ability complete study 7 . Willing able participate give write consent comply study procedures 8 . Willing informed case new clinical pathology discover clinical examination 1 . Exhibiting loss independence basic activity daily live ( ADL score &lt; 4 ) 2 . MMSE score &lt; 24 3 . Dementia determine DSMV criterion 4 . Suffering disease likely lifethreatening shortterm 5 . History presence severe disease ( e.g. , cardiovascular , hepatic , renal ( e.g. , End Stage Renal Disease ) , gastroenteral , respiratory , endocrine , neurologic , psychiatric , immunologic , hematologic disease condition ) could , opinion investigator , interfere subject safety ability complete trial 6 . Food allergy 7 . Taking omega3 dietary supplement contain &gt; 200 mg DHA per day last 6 month 8 . Receiving receive past 3 month physician prescribe vitamin B12 , B3 vitamin Bcomplex 9 . Receiving Alzheimer 's Disease medication ( Galantamine , Memantine Donezepil Rivastigmine ) 10 . Deprived liberty administrative judicial decision , guardianship admit healthcare social institution ( subject nonassisted living facility could recruit ) . 11 . Having participate another clinical study previous month currently participate another study . Subjects meet one follow criterion include PET scan MRIscan subset group : 12 . Wearing pacemaker metal body exclusionary MRI 13 . Claustrophobic Subjects participate PETscan MRIscan subset group , exclude 1year period future project involve investigation use ionize radiation .</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Aging population</keyword>
</DOC>